Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 33 (SMIM33) is a predicted transmembrane protein encoded by a human gene located on chromosome 5. The protein is presumed to localize to intracellular membranes, based on hydrophobicity and signal peptide analyses. Current databases and primary curated sources report that SMIM33's molecular function and involvement in biological processes are unknown, and there are no reported links to disease mechanisms, clinical biomarkers, drug interactions, or safety issues related to human health. No aliases or alternative names have been documented; SMIM33 is distinct from other similarly named proteins such as SMIM3 and SMIM31[2][4][5]. Functional annotation is incomplete, and further research is needed to elucidate its role in cell physiology or pathology.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 33 (SMIM33).